Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Rose

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
Multifunctional supramolecular polymer networks as next-generation consolidants for archaeological wood conservationZarah Walsh, Emma-Rose Janeček, James T Hodgkinson, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 5, 2018
Dear EditorEmma Rose McGlone, Omar A Khan, Will Maynard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2024
Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesityEmma Rose McGlone, David C D Hope, Iona Davies, et al.
The Journal of Biological Chemistry|December 3, 2020
Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptorsBen Jones, Emma Rose McGlone, Zijian Fang, et al.
Molecular Metabolism|May 2, 2021
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonistPhil Pickford, Maria Lucey, Roxana-Maria Rujan, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 18, 2021
Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover studyEmma Rose McGlone, Khalefah Malallah, Joyceline Cuenco, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2019
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trialAlexander Dimitri Miras, Belén Pérez-Pevida, Madhawi Aldhwayan, et al.
Schizophrenia Research|November 30, 2010
A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809Gary Donohoe, James Walters, Derek W Morris, et al.
Chemmedchem|September 21, 2022
Optimization of N-Piperidinyl-Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8-Oxo-Guanine DNA Glycosylase 1Olov Wallner, Armando Cázares-Körner, Emma Rose Scaletti, et al.
Plos Medicine|December 7, 2020
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analysesEmma Rose McGlone, Iain Carey, Vladica Veličković, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
Multifunctional supramolecular polymer networks as next-generation consolidants for archaeological wood conservationZarah Walsh, Emma-Rose Janeček, James T Hodgkinson, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 5, 2018
Dear EditorEmma Rose McGlone, Omar A Khan, Will Maynard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2024
Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesityEmma Rose McGlone, David C D Hope, Iona Davies, et al.
The Journal of Biological Chemistry|December 3, 2020
Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptorsBen Jones, Emma Rose McGlone, Zijian Fang, et al.
Molecular Metabolism|May 2, 2021
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonistPhil Pickford, Maria Lucey, Roxana-Maria Rujan, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 18, 2021
Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover studyEmma Rose McGlone, Khalefah Malallah, Joyceline Cuenco, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2019
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trialAlexander Dimitri Miras, Belén Pérez-Pevida, Madhawi Aldhwayan, et al.
Schizophrenia Research|November 30, 2010
A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809Gary Donohoe, James Walters, Derek W Morris, et al.
Chemmedchem|September 21, 2022
Optimization of N-Piperidinyl-Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8-Oxo-Guanine DNA Glycosylase 1Olov Wallner, Armando Cázares-Körner, Emma Rose Scaletti, et al.
Plos Medicine|December 7, 2020
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analysesEmma Rose McGlone, Iain Carey, Vladica Veličković, et al.
Pageof 10